Status:
COMPLETED
Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients
Lead Sponsor:
MeMed Diagnostics Ltd.
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The proposed project will pilot incorporation of rapid serial measurements of IP-10 into a CDS tool for moderate and severe COVID-19 patients. The tool was applied to all comers with confirmed COVID-...
Eligibility Criteria
Inclusion
- PCR- positive for COVID-19
Exclusion
- \<18 years of age
Key Trial Info
Start Date :
April 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 12 2020
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT04389645
Start Date
April 7 2020
End Date
May 12 2020
Last Update
May 15 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel